Medisan Pharmaceutical Co., Ltd.Lanxi
As of 18 November 2026, for the company name Medisan Pharmaceutical Co., Ltd.Lanxi as recorded, the chemical-drug catalogue lists 2 active records with this name as holder; 47 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
12 acceptance records as first applicant, grouped into 10 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Dotinurad Tablets 2 records · Latest accepted 2026/10/10
Generic · 2
Ertugliflozin Tablets 1 records · Latest accepted 2026/09/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602432 | Generic | 2026/09/29 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
Olopatadine Hydrochloride Granules 1 records · Latest accepted 2025/10/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503792 | Generic | 2025/10/24 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
Pemafibrate Tablets 1 records · Latest accepted 2025/07/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502743 | Generic | 2025/07/30 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
生理氯化钠溶液 · No verified English name 1 records · Latest accepted 2025/07/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501480 | Supplement | 2025/07/24 | Medisan Pharmaceutical Co., Ltd.Lanxi; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Amlodipine Besylate and Benazepril Hydrochloride Capsules 1 records · Latest accepted 2025/03/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501035 | Generic | 2025/03/13 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
Omeprazole Sodium for Injection 1 records · Latest accepted 2025/01/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402259 | Supplement | 2025/01/01 | Medisan Pharmaceutical Co., Ltd.Lanxi; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
甘露醇注射液 · No verified English name 2 records · Latest accepted 2024/07/16
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401049 | Supplement | 2024/07/16 | Medisan Pharmaceutical Co., Ltd.Lanxi; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2401048 | Supplement | 2024/07/16 | Medisan Pharmaceutical Co., Ltd.Lanxi; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Risperidone Orally Disintegrating Tablets 1 records · Latest accepted 2023/07/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301879 | Generic | 2023/07/13 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
Tandospirone Citrate Tablets 1 records · Latest accepted 2022/04/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200635 | Generic | 2022/04/24 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
Changes in the last 90 days
4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 3 applicationsNo longer listed under review: 1 application
- 2026/11/11No longer listed under review
Ertugliflozin Tablets
CYHS2602432
Fact date: 2026/11/11 · Date added to this site: 2026/11/11
Accepted: 2026/09/29
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/10Accepted
Dotinurad Tablets
CYHS2602480
Fact date: 2026/10/10 · Date added to this site: 2026/10/22
View source ↗ - 2026/10/10Accepted
Dotinurad Tablets
CYHS2602479
Fact date: 2026/10/10 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/29Accepted
Ertugliflozin Tablets
CYHS2602432
Fact date: 2026/09/29 · Date added to this site: 2026/10/22
View source ↗
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Dotinurad Tablets | CYHS2602480 | Generic | 2026/10/10 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Dotinurad Tablets | CYHS2602479 | Generic | 2026/10/10 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Olopatadine Hydrochloride Granules | CYHS2503792 | Generic | 2025/10/24 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Pemafibrate Tablets | CYHS2502743 | Generic | 2025/07/30 | Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
Catalogue holder records
2 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Risperidone Orally Disintegrating Tablets | Medisan Pharmaceutical Co., Ltd.Lanxi | Medisan Pharmaceutical Co., Ltd.Lanxi | 国药准字H20249062 | 2024/10/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tandospirone Citrate Tablets | Medisan Pharmaceutical Co., Ltd.Lanxi | Medisan Pharmaceutical Co., Ltd.Lanxi | 国药准字H20234382 | 2023/10/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
47 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 右莰醇 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20260000805 | I | 2026/10/15 | CDE ↗ |
| 葡萄糖酸氯己定溶液 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20260000730 | I | 2026/09/01 | CDE ↗ |
| 奈妥匹坦 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20260000359 | I | 2026/05/19 | CDE ↗ |
| 巴瑞替尼 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20250001134 | I | 2025/11/11 | CDE ↗ |
| 硫酸瑞美吉泮 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20250001049 | I | 2025/09/30 | CDE ↗ |
| 吲哚菁绿 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20250000724 | I | 2025/09/08 | CDE ↗ |
| 盐酸曲唑酮 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20250000868 | I | 2025/08/26 | CDE ↗ |
| 环磷腺苷 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20250000100 | A | 2026/07/28 | CDE ↗ |
| 非奈利酮 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20240001327 | A | 2026/07/14 | CDE ↗ |
| 磷酸芦可替尼 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20240001324 | A | 2026/08/07 | CDE ↗ |
| 氯诺昔康 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20240000025 | I | 2025/08/13 | CDE ↗ |
| 盐酸兰地洛尔 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20230001330 | A | 2025/07/22 | CDE ↗ |
| 布瑞哌唑 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20230001153 | A | 2026/03/06 | CDE ↗ |
| 盐酸莫西沙星 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20230001071 | A | 2025/07/22 | CDE ↗ |
| 甲磺酸倍他司汀 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20230000146 | A | 2024/12/13 | CDE ↗ |
| 罗沙司他 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20230000408 | A | 2024/12/20 | CDE ↗ |
| 米铂 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20230000215 | I | 2023/05/10 | CDE ↗ |
| 醋酸曲普瑞林 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20230000001 | A | 2024/08/22 | CDE ↗ |
| 盐酸倍他司汀 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20220001031 | A | 2025/10/30 | CDE ↗ |
| 盐酸昂丹司琼 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20220000619 | A | 2025/05/09 | CDE ↗ |
| 奥美拉唑钠 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20220000336 | A | 2023/12/21 | CDE ↗ |
| 枸橼酸坦度螺酮 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20220000248 | A | 2025/02/20 | CDE ↗ |
| 马来酸阿塞那平 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20220000119 | I | 2022/03/25 | CDE ↗ |
| 阿立哌唑 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20210000981 | A | 2024/01/17 | CDE ↗ |
| 奥扎格雷钠 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20210000850 | A | 2024/01/17 | CDE ↗ |
| 奥氮平 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20210000364 | A | 2024/01/17 | CDE ↗ |
| 左乙拉西坦 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20200000517 | I | 2020/05/21 | CDE ↗ |
| 右泛醇 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190008338 | A | 2024/06/06 | CDE ↗ |
| 尼麦角林 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190006814 | A | 2024/06/06 | CDE ↗ |
| 米氮平 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190006388 | A | 2026/04/13 | CDE ↗ |
| 丙氨酰谷氨酰胺 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005728 | A | 2025/09/19 | CDE ↗ |
| 甲钴胺 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005725 | A | 2025/09/19 | CDE ↗ |
| 穿琥宁 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005529 | A | 2025/08/16 | CDE ↗ |
| 炎琥宁 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005521 | A | 2025/08/16 | CDE ↗ |
| 细辛脑 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005477 | A | 2025/08/16 | CDE ↗ |
| 奥扎格雷 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005471 | A | 2025/04/23 | CDE ↗ |
| 甲磺酸加贝酯 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005456 | A | 2025/08/16 | CDE ↗ |
| 盐酸艾司洛尔 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005455 | A | 2025/09/18 | CDE ↗ |
| 葡萄糖酸依诺沙星 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005454 | A | 2024/05/24 | CDE ↗ |
| 新鱼腥草素钠 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005453 | A | 2024/06/06 | CDE ↗ |
| 卡络磺钠 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190005452 | A | — | CDE ↗ |
| 羟乙基淀粉130/0.4 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190001364 | A | 2024/06/06 | CDE ↗ |
| 奥沙利铂 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190001328 | A | 2024/06/06 | CDE ↗ |
| 异环磷酰胺 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190001301 | A | 2024/06/06 | CDE ↗ |
| 维库溴铵 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190001271 | A | 2024/06/06 | CDE ↗ |
| 奥拉西坦 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20190000037 | A | 2025/12/16 | CDE ↗ |
| L-苹果酸 · No verified English name | Medisan Pharmaceutical Co., Ltd.Lanxi | Y20170001079 | A | 2026/07/06 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
36 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Trazodone Hydrochloride Sustained-release Tablets | CYHS2602804 | Generic | 2026/11/13 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Pemafibrate Tablets | CYHB2601657 | Supplement | 2026/08/31 | Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Amlodipine Besylate and Benazepril Hydrochloride Capsules | CYHB2601439 | Supplement | 2026/07/27 | Ji Ning Shen Zhou Pharmaceuticals Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| 氟比洛芬凝胶贴膏 · No verified English name | CYHS2601633 | Generic | 2026/07/08 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| 枸橼酸钠血滤置换液 · No verified English name | CYHS2600939 | Generic | 2026/04/24 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Finerenone Tablets | CYHB2600609 | Supplement | 2026/03/27 | Yunpeng Pharmaceutical Group Co., Ltd.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Finerenone Tablets | CYHB2600608 | Supplement | 2026/03/27 | Yunpeng Pharmaceutical Group Co., Ltd.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Finerenone Tablets | CYHS2504169 | Generic | 2025/12/04 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Finerenone Tablets | CYHS2504168 | Generic | 2025/12/04 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Agomelatine Tablets | CYHS2503572 | Generic | 2025/09/29 | Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| 生理氯化钠溶液 · No verified English name | CYHS2503355 | Generic | 2025/09/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Finerenone Tablets | CYHS2503245 | Generic | 2025/09/03 | Anhui Wan Bang Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Finerenone Tablets | CYHS2503244 | Generic | 2025/09/03 | Anhui Wan Bang Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Trazodone Hydrochloride Sustained-release Tablets | CYHS2502782 | Generic | 2025/08/02 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Paracetamol and Ibuprofen Tablets | CYHS2501980 | Generic | 2025/06/05 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Aminophylline Tablets | CYHS2500988 | Generic | 2025/03/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2500362 | Generic | 2025/01/20 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2500361 | Generic | 2025/01/20 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2500360 | Generic | 2025/01/20 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Betahistine Mesilate Tablets | CYHS2404092 | Generic | 2024/11/28 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Moxifloxacin Hydrochloride Tablets | CYHS2403863 | Generic | 2024/11/12 | Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | CYHB2401839 | Supplement | 2024/11/07 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Sodium Thiosulfate Injection | CYHS2403392 | Generic | 2024/10/12 | Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Brexpiprazole Tablets | CYHS2402764 | Generic | 2024/08/23 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Brexpiprazole Tablets | CYHS2402763 | Generic | 2024/08/23 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Brexpiprazole Tablets | CYHS2402259 | Generic | 2024/07/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Brexpiprazole Tablets | CYHS2402257 | Generic | 2024/07/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | CYHB2400799 | Supplement | 2024/06/12 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Nimodipine Tablets | CYHS2401587 | Generic | 2024/05/28 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Morinidazole and Sodium Chloride Injection | CYHS2303528 | Generic | 2023/12/20 | Sichuan Shang Shan Liu Jing Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Roxadustat Capsules | CYHS2302026 | Generic | 2023/07/29 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Roxadustat Capsules | CYHS2302025 | Generic | 2023/07/29 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| 杏芎氯化钠注射液 · No verified English name | CYHB2300624 | Supplement | 2023/03/28 | Hong He Pharmaceutical Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Olanzapine Tablets | CYHS2200979 | Generic | 2022/06/30 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | CYHS2101274 | Generic | 2021/06/08 | Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| 氟比洛芬凝胶贴膏 · No verified English name | CYHS2100166 | Generic | 2021/02/05 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.